Compile Data Set for Download or QSAR
maximum 50k data
Found 347 with Last Name = 'diaz-fernández' and Initial = 'j'
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077877(CHEMBL3417042 | US9611229, 2)
Affinity DataKi:  4.80nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077891(CHEMBL3417066 | US9611229, 12)
Affinity DataKi:  8.70nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077886(CHEMBL3417058 | US9611229, 9)
Affinity DataKi:  10.3nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314366(N-(2-(azepan-1- yl)ethyl)-1-(1- adamantyl)-1H- 1,2...)
Affinity DataKi:  10.8nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077899(CHEMBL3417052 | US9611229, 13)
Affinity DataKi:  11.7nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077905(CHEMBL3417068 | US9611229, 33)
Affinity DataKi:  13.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077892(CHEMBL3417067 | US9611229, 15)
Affinity DataKi:  23.3nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077878(CHEMBL3417043 | US9611229, 3)
Affinity DataKi:  31.1nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077881(CHEMBL3417047 | US9611229, 47)
Affinity DataKi:  31.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077889(CHEMBL3417061 | US9611229, 37)
Affinity DataKi:  32.7nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314373(1-(3-fluorophenyl)-N- (2-(pyrrolidin-1- yl)ethyl)-...)
Affinity DataKi:  34.6nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314290(1-(3,4- dichlorobenzyl)-N- (3-(piperidin-1- yl)pro...)
Affinity DataKi:  34.8nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077888(CHEMBL3417060 | US9611229, 18)
Affinity DataKi:  35.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077883(CHEMBL3417054 | US9611229, 32)
Affinity DataKi:  36.3nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314393(1-(3,4- dichlorobenzyl)-N- (3-(piperidin-1- yl)pro...)
Affinity DataKi:  42.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077893(CHEMBL3417069 | US9611229, 40)
Affinity DataKi:  45.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077882(CHEMBL3417049 | US9611229, 5)
Affinity DataKi:  45.8nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077885(CHEMBL3417057 | US9611229, 4)
Affinity DataKi:  48.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077887(CHEMBL3417059 | US9611229, 17)
Affinity DataKi:  51.7nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077900(CHEMBL3417053 | US9611229, 31)
Affinity DataKi:  56.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077880(CHEMBL3417045 | US9611229, 46)
Affinity DataKi:  57.7nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077890(CHEMBL3417063 | US9611229, 7)
Affinity DataKi:  61.1nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077879(CHEMBL3417044 | US9611229, 39)
Affinity DataKi:  61.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314376(1-cyclohexyl-N-(2-(4- cyclohexylpiperazin- 1-yl)et...)
Affinity DataKi:  62.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314375(1-cyclohexyl-N-(2- (piperidin-1-yl)ethyl)- 1H-1,2,...)
Affinity DataKi:  68.7nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077884(CHEMBL3417055 | US9611229, 43)
Affinity DataKi:  70.2nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM314392(N-(1-(1- adamantyl)-1H- 1,2,3-triazol-4- yl)-N-(2-...)
Affinity DataKi:  71.5nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077869(CHEMBL3417078 | US9611229, 6)
Affinity DataKi:  97.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSigma non-opioid intracellular receptor 1(Mus musculus (Mouse))
Laboratorios Del Dr. Esteve

US Patent
LigandPNGBDBM50077862(CHEMBL3417071 | US9611229, 49)
Affinity DataKi:  99.4nMAssay Description:Brain membrane preparation and binding assays for the 61-receptor were performed as described (DeHaven-Hudkins, D. L., L. C. Fleissner, and F. Y. For...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432197(N-{2-[Benzyl(methyl)amino]ethyl}-N-(1-phenyl-1H-py...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432198(N-{3-[Benzyl(methyl)amino]propyl}-N-(1-phenyl-1H-p...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432215(N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-4-yl)-1H-...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432216(N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-3-yl)-1H-...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432217(N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-2-yl)-1H-...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432219(N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluoropyridin-4...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432220(N-(1-Benzylpiperidin-4-yl)-N-[1-(3-chloropyridin-4...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432248(3-Hydroxy-N-[1-(3-methoxyphenyl)-1H-pyrazol-3-yl]-...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432250(N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-...)
Affinity DataKi: <100nMAssay Description:Human α2δ-1 enriched membranes (2.5 μg) were incubated with 15 nM of radiolabeled [3H]-Gabapentin in assay buffer containing Hepes-KOH...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432253(N-(1-Benzylpiperidin-4-yl)-N-[1-(4-cyanophenyl)-1H...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432254(N-(1-Benzylpiperidin-4-yl)-N-[1-(3-cyanophenyl)-1H...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432256(N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluorophenyl)-1...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432258(N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-(pyri...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432134(N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432135(N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432269(N-[6-(4-Methoxyphenyl)pyrazin-2-yl]-N-(1-methylpip...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432272(N-(1-benzylpiperidin-4-yl)-N-(1-(4-fluorophenyl)-1...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432273(N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-tr...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432273(N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-tr...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432288(N-{(1s,4s)-4-[Benzyl(methyl)amino]cyclohexyl}-N-{1...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Esteve Pharmaceuticals

US Patent
LigandPNGBDBM432289(N-{(1r,4r)-4-[Benzyl(methyl)amino]cyclohexyl}-3-hy...)
Affinity DataKi: <100nMAssay Description:To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 347 total ) | Next | Last >>
Jump to: